ProCE Banner Activity

Overcoming Barriers to Effective Treatment and Enrollment in Clinical Trials for Black and Underserved Patients with Multiple Myeloma: Focus Group Panel Discussion

Slideset

Downloadable slides covering barriers to appropriate care for Black and other underserved patients with multiple myeloma and strategies to address and overcome these barriers

Released: July 31, 2023

Share

Faculty

Camille Edwards

Camille Edwards, MD

CME Co-Course Director
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine, Hematology
Boston, Massachusetts

Natasha Gross-Jean

Natasha Gross-Jean, RN

NCPD Course Advisor
Registered Nurse
Member, Hematology & Oncology Diversity and Inclusion Committee
Boston Medical Center, Hematology 
Boston, Massachusetts

Lynnette Henshaw

Lynnette Henshaw, PharmD, BCOP

Clinical Pharmacy Specialist, Hematology/Oncology
Boston Medical Center 
Boston, Massachusetts

J. Mark Sloan

J. Mark Sloan, MD

CME Course Director
Associate Professor
Boston University Chobanian & Avedisian School of Medicine, Hematology
Boston, Massachusetts

Provided by

Provided by The Boston University School of Medicine Continuing Medical Education Office (BUSM CME), in collaboration with Boston Medical Center (BMC) and Clinical Care Options (CCO)

ProCE Banner
ProCE Banner

Supporters

This activity is supported by independent medical education grants from Bristol Myers Squibb, Karyopharm Therapeutics, Pfizer, Inc., and Regeneron Pharmaceuticals, Inc. This activity is also supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Bristol Myers Squibb

Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.

Karyopharm Therapeutics

Pfizer, Inc.

Regeneron Pharmaceuticals, Inc